Published in World J Gastroenterol on January 28, 2011
Nestin and other putative cancer stem cell markers in pancreatic cancer. Med Mol Morphol (2012) 2.21
Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharmacol (2014) 1.74
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int (2014) 1.11
Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Mol Ther (2011) 1.05
Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol (2013) 1.03
A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Syst Biol (2012) 0.99
Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer. Eur J Histochem (2011) 0.94
Nestin as a marker of cancer stem cells. Cancer Sci (2015) 0.90
Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels. Int J Clin Exp Pathol (2014) 0.83
Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal. Oncotarget (2016) 0.81
Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland. Radiat Oncol (2012) 0.81
Nestin downregulation in rat vascular smooth muscle cells represents an early marker of vascular disease in experimental type I diabetes. Cardiovasc Diabetol (2014) 0.80
Characterization of Nestin, a Selective Marker for Bone Marrow Derived Mesenchymal Stem Cells. Stem Cells Int (2015) 0.80
Profiles of cancer stem cell subpopulations in cholangiocarcinomas. Am J Pathol (2015) 0.80
Roles of long non-coding RNAs in gastric cancer metastasis. World J Gastroenterol (2015) 0.79
Nestin depletion induces melanoma matrix metalloproteinases and invasion. Lab Invest (2014) 0.78
Knockdown of Nestin inhibits proliferation and migration of colorectal cancer cells. Int J Clin Exp Pathol (2015) 0.76
Isolation and characterization of side population cells from the human ovarian cancer cell line SK-OV-3. Exp Ther Med (2015) 0.76
Immunohistochemical evaluation of stem cell markers and signal transducer and activator of transcription 6 (STAT6) in solitary fibrous tumors. Int J Clin Exp Pathol (2015) 0.75
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer (2017) 0.75
The changes of angiogenesis and immune cell infiltration in the intra- and peri-tumoral melanoma microenvironment. Int J Mol Sci (2015) 0.75
Reply to a letter to the editor: Nestin as a novel therapeutic target for cancer. Med Mol Morphol (2013) 0.75
Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML. Bone Marrow Transplant (2015) 0.75
Increased expression of nestin in human pterygial epithelium. Int J Ophthalmol (2013) 0.75
Single-cell analysis reveals a nestin(+) tendon stem/progenitor cell population with strong tenogenic potentiality. Sci Adv (2016) 0.75
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (1998) 21.13
CNS stem cells express a new class of intermediate filament protein. Cell (1990) 11.96
Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch (2001) 10.93
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci (1997) 6.74
Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol (2000) 6.21
Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science (2001) 4.69
Cancer stem cells in nervous system tumors. Oncogene (2004) 4.09
Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron (1994) 4.00
Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet (1992) 3.77
The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res (1976) 3.47
CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol (1998) 3.43
Nestin expression--a property of multi-lineage progenitor cells? Cell Mol Life Sci (2004) 3.26
Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell (1988) 2.99
Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes (2001) 2.95
GFAP and astrogliosis. Brain Pathol (1994) 2.79
Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res (2004) 2.67
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther (2009) 2.61
Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology (1999) 2.45
Increased expression of stem cell markers in malignant melanoma. Mod Pathol (2006) 2.39
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc Natl Acad Sci U S A (2007) 2.18
Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol (1986) 2.12
Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol (2000) 2.08
Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J Cell Biol (1995) 2.05
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J Neurosci (1988) 2.02
Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res (1992) 2.01
Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg (1997) 2.01
Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci U S A (2004) 2.00
Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol (2005) 1.80
Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis. Cancer Res (2007) 1.76
Transient expression of the intermediate filament nestin during skeletal muscle development. J Cell Sci (1993) 1.76
Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype. Gastroenterology (1999) 1.67
Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments. J Cell Sci (1992) 1.65
Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol (1992) 1.60
Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol (2007) 1.58
Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res (1994) 1.58
Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer (1997) 1.55
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer (2002) 1.52
The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol (2008) 1.49
CD34 expression by gastrointestinal tract stromal tumors. Hum Pathol (1994) 1.49
Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol (2007) 1.46
Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp Neurol (2000) 1.45
Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis. Mol Biol Cell (2003) 1.38
Identification of neovasculature using nestin in colorectal cancer. Int J Oncol (2007) 1.36
In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate (2009) 1.33
Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev (2008) 1.32
Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem (2010) 1.32
Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase. J Biol Chem (2001) 1.31
Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas. Mech Dev (2004) 1.31
Nestin expression in pancreatic exocrine cell lineages. Mech Dev (2004) 1.30
Re-expression of the intermediate filament nestin in reactive astrocytes. Neurobiol Dis (1995) 1.29
Nestin as a marker for proliferative endothelium in gliomas. Lab Invest (2002) 1.29
Nestin expression by newly formed human blood vessels. Stem Cells Dev (2004) 1.28
Origin of interstitial cells of Cajal in the mouse intestine. Dev Biol (1996) 1.28
Reactive astrocytes express the embryonic intermediate neurofilament nestin. Neuroreport (1994) 1.27
Immunohistochemical detection of nestin in pediatric brain tumors. J Histochem Cytochem (2002) 1.24
Adult nestin-expressing subependymal cells differentiate to astrocytes in response to brain injury. Eur J Neurosci (1997) 1.24
Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol (2003) 1.24
Expression of the intermediate filament nestin during rodent tooth development. Int J Dev Biol (1995) 1.22
Myogenesis and the intermediate filament protein, nestin. Dev Biol (1994) 1.20
Granular cell tumours of the gastrointestinal tract: expression of nestin and clinicopathological evaluation of 11 patients. Histopathology (2006) 1.19
Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res (2007) 1.17
Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Sci (2009) 1.17
The intermediate filament protein nestin occurs transiently in differentiating testis of rat and mouse. Differentiation (1997) 1.16
Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun (2000) 1.15
Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma. Exp Dermatol (2010) 1.14
Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension. Cell Cycle (2010) 1.13
Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer (1997) 1.13
Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Cancer Res (2009) 1.11
Nestin expression in pancreatic stellate cells and angiogenic endothelial cells. Histochem Cell Biol (2002) 1.11
A rod end deletion in the intermediate filament protein nestin alters its subcellular localization in neuroepithelial cells of transgenic mice. J Cell Sci (1998) 1.10
Clinical implications for nestin protein expression in breast cancer. Cancer Sci (2009) 1.10
Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol (2008) 1.10
Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes (2003) 1.08
Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. Mech Dev (2002) 1.08
Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest (1998) 1.08
Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol (2001) 1.07
Epigenetic hierarchy governing Nestin expression. Stem Cells (2009) 1.05
Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res (2004) 1.04
Migratory paths and phenotypic choices of clonally related cells in the avian optic tectum. Neuron (1991) 1.02
Defined localization of nestin-expressing cells in L-arginine-induced acute pancreatitis. Pancreas (2006) 1.01
Nestin is expressed in vascular endothelial cells in the adult human pancreas. J Histochem Cytochem (2003) 1.01
Characterization and isolation of promoter-defined nestin-positive cells from the human fetal pancreas. Diabetes (2003) 1.01
Characterization and promoter analysis of the mouse nestin gene. FEBS Lett (2004) 1.01
The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep (2010) 0.99
Nestin expression during mouse eye and lens development. Mech Dev (2000) 0.99
Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol (2002) 0.98
Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol (2007) 0.98
The potential of nestin-expressing hair follicle stem cells in regenerative medicine. Expert Opin Biol Ther (2007) 0.98
Immunohistochemical analysis of nestin and c-kit and their significance in pancreatic tumors. Pathol Int (2007) 0.98
SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells. J Invest Dermatol (2008) 0.97
Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. Prostate (2010) 0.96
Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers. Gynecol Oncol (2004) 0.95
Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95
Restoration of myofiber continuity after transection injury in the rat soleus. Neuromuscul Disord (2004) 0.93
Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas. APMIS (2002) 0.93
Nestin expression in ganglioglioma. Exp Neurol (2002) 0.93
Expression of nestin mRNA is a differentiation marker in thyroid tumors. Cancer Lett (2009) 0.92
Malignant afferent loop obstruction following pancreaticoduodenectomy: report of two cases. J Nippon Med Sch (2006) 1.48
Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res (2002) 1.48
Identification of neovasculature using nestin in colorectal cancer. Int J Oncol (2007) 1.36
Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol (2005) 1.13
Basic FGF and Ki-67 proteins useful for immunohistological diagnostic evaluations in malignant solitary fibrous tumor. Pathol Int (2003) 1.13
Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther (2011) 1.13
Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am J Pathol (2007) 1.10
Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol (2008) 1.10
Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci (2007) 1.07
Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol Rep (2006) 1.04
CD44 in human glioma correlates with histopathological grade and cell migration. Pathol Int (2012) 1.04
Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway. Exp Mol Pathol (2004) 1.02
Defined localization of nestin-expressing cells in L-arginine-induced acute pancreatitis. Pancreas (2006) 1.01
Expression of lumican in human colorectal cancer cells. Pathol Int (2002) 1.00
Lung toxicity of 16 fine particles on intratracheal instillation in a bioassay model using f344 male rats. Toxicol Pathol (2008) 0.99
Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas. J Hepatobiliary Pancreat Surg (2005) 0.97
Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Int J Oncol (2012) 0.97
Nodular fasciitis in the parotid gland: a case report and review of the literature. Diagn Cytopathol (2013) 0.97
Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas. Oncol Rep (2011) 0.96
Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis. Int J Oncol (2006) 0.96
Combined neuroendocrine cell carcinoma and adenocarcinoma of the gallbladder: report of a case. J Nippon Med Sch (2006) 0.96
Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Am J Pathol (2012) 0.95
Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer. Oncol Rep (2007) 0.92
Successful emergency enterectomy for bleeding ileal varices in a patient with liver cirrhosis. J Nippon Med Sch (2006) 0.92
Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells. Int J Oncol (2007) 0.91
A case of metastatic hemangiopericytoma occurring 16 years after initial presentation: with special reference to the clinical behavior and treatment of metastatic hemangiopericytoma. J Nippon Med Sch (2009) 0.91
Pathogenesis and protection of ischemia and reperfusion injury in myocardium. J Nippon Med Sch (2003) 0.91
A case of xanthogranulomatous cholecystitis preoperatively diagnosed with contrast-enhanced ultrasonography. J Nippon Med Sch (2011) 0.90
Comparison of fixation methods for preservation of morphology, RNAs, and proteins from paraffin-embedded human cancer cell-implanted mouse models. J Histochem Cytochem (2011) 0.90
Ruptured metastatic liver tumor from an alpha-fetoprotein-producing gastric cancer. J Nippon Med Sch (2005) 0.90
Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Ann Thorac Surg (2011) 0.90
Case of an inflammatory fibroid polyp of the cecum. J Nippon Med Sch (2008) 0.89
Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer. Int J Oncol (2010) 0.88
Morphological and cytoskeletal changes of pancreatic cancer cells in three-dimensional spheroidal culture. Med Mol Morphol (2011) 0.88
Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int J Oncol (2008) 0.88
Bioassay by intratracheal instillation for detection of lung toxicity due to fine particles in F344 male rats. Exp Toxicol Pathol (2006) 0.88
Clinicopathological features of 30 autopsy cases of pancreatic carcinoma. J Nippon Med Sch (2012) 0.87
Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer. Oncol Rep (2005) 0.87
Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis. Oncol Rep (2006) 0.87
Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol Rep (2004) 0.87
Dedifferentiated liposarcoma arising from the mesocolon ascendens: report of a case. J Nippon Med Sch (2012) 0.87
Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Exp Mol Pathol (2002) 0.86
Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Int J Oncol (2012) 0.86
Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer. Cancer Lett (2011) 0.86
Expression of lumican in hidroacanthoma simplex and clonal-type seborrheic keratosis as a potent differential diagnostic marker. Am J Dermatopathol (2014) 0.86
Follicular dendritic cell sarcoma with microtubuloreticular structure and virus-like particle production in vitro. Pathol Int (2009) 0.85
8-Methoxypsoralen, a potent human CYP2A6 inhibitor, inhibits lung adenocarcinoma development induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Mol Med Rep (2011) 0.85
Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Int J Oncol (2011) 0.85
Histological hair removal study by ruby or alexandrite laser with comparative study on the effects of wavelength and fluence. J Cosmet Laser Ther (2004) 0.85
Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer. Cancer Lett (2012) 0.84
Establishment of a bioassay model for lung cancer chemoprevention initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice. Exp Toxicol Pathol (2008) 0.84
Differential distribution of fibroblast growth factor (FGF)-7 and FGF-10 in L-arginine-induced acute pancreatitis. Exp Mol Pathol (2002) 0.84
Re-expression of reduced VEGF activity in liver metastases of experimental pancreatic cancer. J Nippon Med Sch (2005) 0.84
Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer. Cancer Sci (2014) 0.84
Effect of morpholino antisense oligonucleotide against lumican mRNA in human embryonic kidney (HEK) 293 cells. Pathol Int (2004) 0.83
Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett (2006) 0.83
Squamous cell carcinoma arising from recurrent anal fistula. J Nippon Med Sch (2007) 0.83
Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival. Oncol Rep (2003) 0.82
Major arterioportal shunt caused by hepatocellular carcinoma. J Nippon Med Sch (2007) 0.82
[Pancreaticoduodenal lymph node metastasis of neuroendocrine carcinoma of unknown primary associated with duodenal carcinoma]. Nihon Shokakibyo Gakkai Zasshi (2010) 0.82
Hepatosplenic and muscular sarcoidosis: characterization with MR imaging. Magn Reson Med Sci (2012) 0.82
Relationship between grade of fibrosis in pancreatic stump and postoperative pancreatic exocrine activity after pancreaticoduodenectomy: with special reference to insufficiency of pancreaticointestinal anastomosis. J Nippon Med Sch (2002) 0.82
Keratinocyte growth factor-transfection-stimulated adhesion of colorectal cancer cells to extracellular matrices. Exp Mol Pathol (2007) 0.82
Cholecystitis caused by infiltration of immature myeloid cells: a case report. J Nippon Med Sch (2006) 0.82
Immunohistochemical localization of endothelial cell markers in solitary fibrous tumor. Pathol Int (2002) 0.82
Multicentric pancreatic intraepithelial neoplasias (PanINs) presenting with the clinical features of chronic pancreatitis. J Hepatobiliary Pancreat Surg (2008) 0.81
Expression of E-cadherin catenin and C-erbB-2 gene products in invasive ductal-type breast carcinomas. J Nippon Med Sch (2002) 0.81
Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice. Oncol Rep (2008) 0.81
Expression of keratinocyte growth factor receptor correlates with expansive growth and early stage of gastric cancer. Int J Oncol (2006) 0.81
Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma. J Invest Dermatol (2013) 0.80
Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells. Exp Mol Pathol (2010) 0.80
Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor. Carcinogenesis (2005) 0.80
Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer. Int J Oncol (2011) 0.80
Deciduoid mesothelioma in the pelvic cavity. Pathol Int (2004) 0.80
Different expression levels of lumican in human carcinoid tumor and neuroendocrine cell carcinoma. Int J Oncol (2005) 0.79
Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells. Int J Oncol (2009) 0.79
Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach. J Gastroenterol Hepatol (2008) 0.79
Clinicopathologic study on pancreatic groove carcinoma. Pancreas (2006) 0.79
Lumican as a novel marker for differential diagnosis of Bowen disease and actinic keratosis. Am J Dermatopathol (2013) 0.79
Fractional CO2 laser for the treatment of acne scars. J Cosmet Dermatol (2011) 0.79
Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in vascular smooth muscle cells. Pathol Int (2003) 0.79
Morphological and cytoskeletal alterations of nervous system tumor cells with different culturing methods. Int J Oncol (2011) 0.79
Spermatic cord tumor metastatic from stomach cancer 1 year after curative gastrectomy. J Nippon Med Sch (2013) 0.79
Localization of cytochrome P4502E1 enzyme in normal and cancerous gastric mucosa and association with its genetic polymorphism in unoperated and remnant stomach. J Nippon Med Sch (2011) 0.79
Histological study of papillary thyroid carcinoma treated with percutaneous ethanol injection therapy. Pathol Int (2002) 0.79
Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer. Int J Oncol (2012) 0.78
Evaluation of neuronal protective effects of xanthine oxidoreductase inhibitors on severe whole-brain ischemia in mouse model and analysis of xanthine oxidoreductase activity in the mouse brain. Neurol Med Chir (Tokyo) (2014) 0.78